The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.30.2.114

With some schizophrenics, response to antipsychotic drugs is best monitored in the hospital. They include dysphoric responders, those whose illness has been only minimally responsive to antipsychotic drugs, and habitual noncompliers with drug regimen. Dysphoric responses need to be acknowledged and regarded as a danger signal. Patients whose illness is only modestly sensitive to drugs are particularly in danger of psychotoxicity due to excessive dosage. Habitual noncompliers have little investment in staying well, and cannot be expected to bear even mild drug side-effects.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.